Digital Aftercare for Wrist and Clavicle Fractures
Launched by LUZERNER KANTONSSPITAL · Jun 27, 2025
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to care for adults after surgery for certain broken bones in the wrist or collarbone. Instead of the usual in-person check-ups, this study will compare traditional follow-up visits with a digital aftercare program that patients can access through a smartphone app. The main goal is to see how well patients recover function in their wrist or shoulder three months after surgery. The study will also look at other important factors like how well the joint moves, how satisfied patients are with their care, their overall quality of life, any complications, healthcare costs, and time off work. For those using the app, researchers will check how easy it is to use and whether patients stick with the program.
Adults between 18 and 65 years old who have had surgery for a straightforward wrist or collarbone fracture may be eligible, as long as they can use a smartphone and understand German to complete questionnaires. People with more complex injuries, those who cannot use a smartphone, or who have certain health or language challenges won’t be able to join. Participants can expect to be followed for at least three months after their surgery, either through regular doctor visits or by using the digital program, to help track their recovery and share their experiences. This study hopes to find out if digital aftercare can be just as effective and convenient as traditional care, potentially making recovery easier and more accessible for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 65 years
- • Surgically treated, uncomplicated distal radius or clavicle fracture
- • Use of a smartphone (iOS or Android)
- • Ability to understand German and complete study-related questionnaires
- • Provided written informed consent
- Exclusion Criteria:
- • Polytrauma or additional injuries to the same upper extremity
- • No access to or inability to use a smartphone
- • Cognitive, psychiatric, or language barriers impairing participation
- • Pregnancy
- • Inability or unwillingness to comply with the study protocol
About Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) is a leading academic hospital located in Lucerne, Switzerland, dedicated to providing high-quality healthcare and advancing medical research. As a prominent clinical trial sponsor, LUKS is committed to fostering innovation in medical treatments and therapies through rigorous clinical studies. The institution emphasizes collaboration with multidisciplinary teams of healthcare professionals, researchers, and academic partners to ensure that its trials adhere to the highest ethical standards and regulatory requirements. With a focus on improving patient outcomes, LUKS leverages its state-of-the-art facilities and expertise to contribute significantly to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lucerne, , Switzerland
Patients applied
Trial Officials
Frank Beeres, Prof. MD
Principal Investigator
Luzerner Kantonsspital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported